Exousia Bio (LMMY) Annual Balance Sheets

Annual · GAAP · USD millions
Access LMMY quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Exousia Bio.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/LMMY/balance-sheets
https://api.csimarket.com/api/v1/companies/LMMY/fundamentals
https://api.csimarket.com/api/v1/companies/LMMY/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Annual Report, GAAP in USD millions
ITEM
(May 31 2025)
(May 31 2024) (May 31 2023)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.00
Notes Receivable, Current0.00
Total Current Assets0.00
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Total Assets0.00
Liabilities
Accrued Liabilities, Current0.00
Total Current Liabilities0.00
Long-term debt0.00
Total Long-term Debt0.00
Total Liabilities0.00
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock0.03
Retained Earnings / Accumulated Deficit-0.03
Common Stockholder's Equity0.00
Total Stockholder's Equity0.00
Liabilities & Stockholder's Equity0.00
4 historic quarters locked

Sign in to unlock the full Exousia Bio balance sheet history.

About Lamy Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-25-007621

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI